HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tatjana Zabelina Selected Research
Tatjana Zabelina Research Topics
Disease
16
Primary Myelofibrosis (Myelosclerosis)
01/2023 - 12/2002
12
Multiple Myeloma
03/2013 - 08/2002
10
Graft vs Host Disease (Graft-Versus-Host Disease)
11/2020 - 03/2002
6
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2020 - 01/2011
6
Bronchiolitis Obliterans Syndrome
10/2018 - 03/2002
5
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2021 - 01/2009
5
Neoplasms (Cancer)
03/2014 - 05/2006
4
Leukemia
01/2020 - 10/2006
4
Residual Neoplasm
03/2014 - 05/2006
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 01/2009
3
Polycythemia Vera
07/2017 - 12/2009
2
B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 01/2010
2
Essential Thrombocythemia
07/2017 - 06/2014
2
Thrombocytopenia (Thrombopenia)
04/2009 - 06/2006
1
Cytopenia
10/2018
1
Colitis
10/2018
1
Fever of Unknown Origin
10/2018
1
Lymphoma (Lymphomas)
10/2015
1
Toxoplasmosis
01/2015
1
Infections
01/2015
1
Fibrosis (Cirrhosis)
02/2011
1
Viral Encephalitis
01/2011
1
Aplastic Anemia (Anemia, Hypoplastic)
01/2011
1
Encephalitis (Encephalitis, Rasmussen)
01/2011
1
Progressive Multifocal Leukoencephalopathy
01/2011
1
Hodgkin Disease (Hodgkin's Disease)
01/2011
1
Thrombocytosis (Thrombocythemia)
12/2009
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2009
1
Hematologic Neoplasms (Hematological Malignancy)
08/2008
1
Body Weight (Weight, Body)
08/2008
1
Leukopenia
06/2006
1
Peripheral Nervous System Diseases (PNS Diseases)
11/2004
1
Pathologic Complete Response
10/2004
1
13q deletion syndrome
06/2004
Drug/Important Bio-Agent (IBA)
8
fludarabine
IBA
01/2016 - 12/2002
8
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
09/2008 - 12/2002
6
Busulfan (Busulfex)
FDA Link
09/2016 - 12/2002
5
Melphalan (Alkeran)
FDA Link
Generic
01/2016 - 12/2002
2
Steroids
IBA
01/2020 - 10/2018
2
Tyrosine Kinase Inhibitors
IBA
04/2013 - 01/2009
2
Alemtuzumab (Campath)
FDA Link
01/2011 - 06/2005
2
Ligands
IBA
10/2006 - 06/2005
2
Cyclosporine (Ciclosporin)
FDA Link
Generic
06/2006 - 03/2002
1
axicabtagene ciloleucel
IBA
01/2021
1
teduglutide
IBA
01/2020
1
Glucagon-Like Peptide 2
IBA
01/2020
1
ruxolitinib
IBA
10/2018
1
Ganciclovir (Cytovene)
FDA Link
Generic
10/2018
1
Immunoglobulin G (IgG)
IBA
10/2015
1
Pentamidine (NebuPent)
FDA Link
Generic
01/2015
1
Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)
FDA Link
Generic
01/2015
1
Atovaquone (Mepron)
FDA Link
01/2015
1
Serum Albumin
IBA
05/2014
1
Biomarkers (Surrogate Marker)
IBA
03/2014
1
Rituximab (Mabthera)
FDA Link
01/2010
1
pegfilgrastim (Neulasta)
FDA Link
04/2009
1
KIR Receptors
IBA
10/2006
1
Immunoglobulins (Immunoglobulin)
IBA
10/2006
1
Bortezomib (Velcade)
FDA Link
06/2006
1
Antigens
IBA
06/2005
1
Thalidomide (Thalomid)
FDA Link
11/2004
1
Methotrexate (Mexate)
FDA Link
Generic
03/2002
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
03/2002
Therapy/Procedure
43
Stem Cell Transplantation
01/2023 - 08/2002
10
Transplantation
11/2020 - 12/2002
8
Hematopoietic Stem Cell Transplantation
11/2021 - 12/2010
5
Homologous Transplantation
05/2006 - 03/2002
3
Therapeutics
01/2019 - 04/2013
1
Cell Transplantation
01/2020
1
Chemoradiotherapy
01/2011
1
Immunotherapy
07/2009
1
Drug Therapy (Chemotherapy)
06/2004
1
Autologous Transplantation
08/2002